Myocardial recovery: A focus on the impact of left ventricular assist devices

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 5, 2014, Pages 589-600

  Halbreiner, M Scott ^a   Cruz, Vincent ^b   Starling, Randall ^a   Soltesz, Edward ^a   Smedira, Nicholas ^a   Moravec, Christine ^a   Moazami, Nader ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

heart failure; myocardial recovery; ventricular assist devices; ventricular recovery; ventricular remodeling

Indexed keywords

CALCIUM;

ADRENERGIC SYSTEM; ASSISTED CIRCULATION; CLINICAL PROTOCOL; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GEOMETRY; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; METABOLISM; NONISCHEMIC CARDIOMYOPATHY; PHYSIOLOGICAL PROCESS; PULSATILE FLOW GENERATOR; RECURRENT DISEASE; REVIEW; EQUIPMENT DESIGN; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE REMODELING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE;

EQUIPMENT DESIGN; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MYOCARDIUM; PREVALENCE; VENTRICULAR REMODELING;

EID: 84899089987     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.909729     Document Type: Review

References (84)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125(1): e2-220
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2013 update a report from the American Heart Association. Circulation 2013;127(1): e6-245
3. Death: final Data for 2009 National Vital Statistics Reports. Available from: www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60-03.pdf
4. Heart Failure Fact Sheet|Data & Statistics| DHDSP|CDC. Available from: www.cdc.gov/dhdsp/data-statistics/fact-sheets/fs-heart-failure.htm
5. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348(20):2007-18
6. Butler CR, Jugdutt BI. The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev 2012; 17(4-5):615-33
7. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirtieth Official Adult Heart Transplant Report-2013; focus theme: age. J Heart Lung Transplant 2013; 32(10):951-64
8. Organ Procurement and Transplantation Network Waiting List Data. (2014). Available from: http://optn.transplant.hrsa.gov/data/default.asp
9. Heart, 2011 SRTR & OPTN Annual Data Report. Available from: http://srtr. transplant.hrsa.gov/annual-reports/2011/flash/05-heart/index.html
10. Kirklin JK, Naftel DC, Pagani FD, et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012;144(3):584-603. discussion 597-8
11. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014;370(1):33-40
12. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009;208(5):755-61. discussion 761-762
13. Bartoli CR, Giridharan GA, Litwak KN, et al. Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle. ASAIO J 1992;2010:56(5):410-16
14. Loor G, Gonzalez-Stawinski G. Pulsatile vs. continuous flow in ventricular assist device therapy. Best Pract Res Clin Anaesthesiol 2012;26(2):105-15
15. Birks EJ. Molecular changes after left ventricular assist device support for heart failure. Circ Res 2013;113(6):777-91
16. Birks EJ. Myocardial recovery in patients with chronic heart failure: is it real? J Card Surg 2010;25(4):472-7
17. Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail 2011;4(2): 224-33
18. Kato TS, Chokshi A, Singh P, et al. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail 2011;4(5):546-53
19. Drakos SG, Kfoury AG, Stehlik J, et al. Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation 2012;126(2):230-41
20. Mann DL, Burkhoff D. Is myocardial recovery possible and how do you measure it? Curr Cardiol Rep 2012;14(3):293-8
21. Drakos SG, Wever-Pinzon O, Selzman CH, et al. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol 2013;61(19):1985-94
22. Boehmer JP, Starling RC, Cooper LT, et al. Left ventricular assist device support and. myocardial recovery in recent onset cardiomyopathy. J Card Fail 2012;18(10): 755-61
23. Morgan JA, Brewer RJ, Nemeh HW, et al. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation. ASAIO J 58(6):574-7
24. Simon MA, Primack BA, Teuteberg J, et al. Left ventricular remodeling and myocardial recovery on mechanical circulatory support. J Card Fail 2010;16(2):99-105
25. Dandel M, Weng Y, Siniawski H, et al. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation 2012;126(11 Suppl 1):S9-19
26. Ambardekar AV, Walker JS, Walker LA, et al. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail 2011; 4(4):425-32
27. Drakos SG, Kfoury AG, Selzman CH, et al. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol 2011;26(3):245-55
28. Hall JL, Fermin DR, Birks EJ, et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol 2011;57(6):641-52
29. Koitabashi N, Kass DA. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol 2012;9(3): 147-57
30. Abraham WT, Smith SA. Devices in the management of advanced, chronic heart failure. Nat Rev Cardiol 2013;10(2):98-110
31. Moazami N, Hoercher KJ, Fukamachi K, et al. Mechanical circulatory support for heart failure: past, present and a look at the future. Expert Rev Med Devices 2013;10(1):55-71
32. Birks EJ, George RS. Molecular changes occurring during reverse remodelling following left ventricular assist device support. J Cardiovasc Transl Res 2010;3(6):635-42
33. Lompré A-M, Hajjar RJ, Harding SE, et al. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 2010;121(6):822-30
34. Jessup M, Greenberg B, Mancini D, et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011; 124(3):304-13
35. Triposkiadis F, Karayannis G, Giamouzis G, et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009;54(19):1747-62
36. Spinale FG, Zile MR. Integrating the myocardial matrix into heart failure recognition and management. Circ Res 2013;113(6):725-38
37. Saito S, Matsumiya G, Sakaguchi T, et al. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist. J Heart Lung Transplant 2010;29(6):672-9
38. Felkin LE, Lara-Pezzi E, George R, et al. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support. J Heart Lung Transplant 2009; 28(2):117-22
39. Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 2013; 113(6):709-24
40. Chokshi A, Drosatos K, Cheema FH, et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 2012;125(23):2844-53
41. Khan RS, Kato TS, Chokshi A, et al. Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail 2012;5(3):340-8
42. Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 2011;16(1):13-21
43. De Weger RA, Schipper MEI, Siera-de Koning E, et al. Proteomic profiling of the human failing heart after left ventricular assist device support. J Heart Lung Transplant 2011;30(5):497-506
44. Matkovich SJ, Van Booven DJ, Youker KA, et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009;119(9):1263-71
45. Ramani R, Vela D, Segura A, et al. A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol 2011; 58(22):2270-8
46. Ibrahim M, Yacoub MH. Bridge to recovery and weaning protocols. Heart Fail Clin 2014(10(1 Suppl):S47-55
47. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62(3):675-81.discussion 681-2
48. Levin HR, Oz MC, Catanese KA, et al. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant 1996;15(8):840-2
49. Malliaras KG, Terrovitis JV, Drakos SG, Nanas JN. Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. J Cardiovasc Transl Res 2009;2(1):114-25
50. Goldstein DJ, Maybaum S, MacGillivray TE, et al. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail 2012;18(5):392-5
51. Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011;123(4):381-90
52. Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115(19):2497-505
53. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355(18):1873-84
54. Remission from Stage D Heart Failure - ClinicalTrials.gov. Available from: http://clinicaltrials.gov/ct2/show/NCT01774656? term=nct01774656&rank= 1
55. Ohnishi S, Ohgushi H, Kitamura S, Nagaya N. Mesenchymal Stem Cells for the Treatment of Heart Failure. Int J Hematol 2007;86(1):17-21
56. The evaluation of VAD InterVEntion before inotropic therapy (REVIVE-IT)- ClinicalTrials.gov. Available from: http://clinicaltrials.gov/ct2/show/ NCT01369407? term=nct01369407&rank=1
57. Lamarche Y, Kearns M, Josan K, et al. Successful weaning and explantation of the Heartmate II left ventricular assist device. Can J Cardiol 2011;27(3):358-62
58. Levin HR, Oz MC, Catanese KA, et al. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant 1996;15(8):840-2
59. Müller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96(2): 542-9
60. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98(22):2383-9
61. Sun BC, Catanese KA, Spanier TB, et al. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 1999; 68(2):688-94
62. Helman DN, Maybaum SW, Morales DL, et al. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable?. Ann Thorac Surg 2000;70(4): 1255-8
63. Ueno T, Bergin P, Richardson M, Esmore DS. Bridge to recovery with a left ventricular assist device for fulminant acute myocarditis. Ann Thorac Surg 2000;69(1): 284-6
64. Hetzer R, Müller JH, Weng Y, et al. Bridging-to-recovery. Ann Thorac Surg 2001;71(3 Suppl):S109-13; discussion S114-115
65. El-Banayosy A, Arusoglu L, Kizner L, et al. Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 2001;20(2): 209-10
66. Bruckner BA, Stetson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001;20(4):457-64
67. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21(5):516-21
68. Khan T, Delgado RM, Radovancevic B, et al. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 2003;22(2):137-46
69. Gorcsan J 3rd, Severyn D, Murali S, Kormos RL. Non-invasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal. J Heart Lung Transplant 2003;22(12):1304-13
70. Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005;112(9 Suppl):I37-45
71. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005; 112(9 Suppl):I32-6
72. Matsumiya G, Monta O, Fukushima N, et al. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?. J Thorac Cardiovasc Surg 2005;130(3):699-704
73. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355(18):1873-84
74. George I, Xydas S, Mancini DM, et al. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant 2006;25(9):1084-90
75. Liden H, Karason K, Bergh C-H, et al. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery. Eur J Heart Fail 2007;9(5):525-30
76. Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115(19):2497-505
77. Klotz S, Jan Danser AH, Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008;97(2-3):479-96
78. Dandel M, Weng Y, Siniawski H, et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008;118(14 Suppl):S94-105
79. Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011;123(4):381-90
80. Lamarche Y, Kearns M, Josan K, et al. Successful weaning and explantation of the Heartmate II left ventricular assist device. Can J Cardiol 2011;27(3):358-62
81. Kinoshita O, Kimura M. Kashiwa K, et al. Mid-long term result of implantable ventricular assist device treatment for endstage heart failure in the University of Tokyo Hospital. Kyobu Geka 2013;66(1): 51-6
82. Patel SR, Saeed O, Murthy S, et al. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a singlearm prospective study. J Heart Lung Transplant 2013;32(3):305-12
83. Yagdi T, Oguz E, Engin C, et al. Changing face of heart failure surgery. Transplant Proc 2012;44(6):1729-31
84. Nasir A, Bonde P, Graham ANJ. Ventricular assist device therapy in postcardiotomy cardiogenic shock: historical outcomes and current trends. Interact Cardiovasc Thorac Surg 2012;14(5):585-7